Cholesterol-lowering therapy may retard the progression of diabetic nephropathy

[1]  S M Grundy,et al.  Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Lutz Heinemann,et al.  Smoking Is Associated With Progression of Diabetic Nephropathy , 1994, Diabetes Care.

[3]  K. Lai,et al.  Effect of lovastatin on serum lipid profile in the treatment of dyslipoproteinaemia in uraemic patients on continuous ambulatory peritoneal dialysis. , 1993, Australian and New Zealand journal of medicine.

[4]  T. Kodama,et al.  Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. , 1993, Kidney international.

[5]  H. Yeung,et al.  Lovastatin in glomerulonephritis patients with hyperlipidaemia and heavy proteinuria , 1992, Pediatric Nephrology.

[6]  P. Kearns,et al.  Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. , 1991, JPEN. Journal of parenteral and enteral nutrition.

[7]  B. Feldt-Rasmussen,et al.  Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients: an update of the Steno studies , 1991, Diabetologia.

[8]  H. Mulec,et al.  Relation between serum cholesterol and diabetic nephropathy , 1990, The Lancet.

[9]  K. Utsunomiya,et al.  Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus. , 1990, Japanese journal of medicine.

[10]  M. Weintraub,et al.  HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. , 1989, Circulation.

[11]  L. Heinemann,et al.  Comparison of Methods for Determination of Microalbuminuria in Diabetic Patients , 1989, Diabetic medicine : a journal of the British Diabetic Association.

[12]  J. Wasserman,et al.  Interactions of low density lipoprotein with rat mesangial cells. , 1989, Kidney international.

[13]  B. Kasiske,et al.  Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. , 1988, Kidney international.

[14]  B. Kasiske,et al.  Pharmacologic Treatment of Hyperlipidemia Reduces Glomerular Injury in Rat 5/6 Nephrectomy Model of Chronic Renal Failure , 1988, Circulation research.

[15]  S. Grundy,et al.  Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.

[16]  M. Karnovsky,et al.  Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation. , 1987, Kidney international.

[17]  J. Tobert.  New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase. , 1987, Circulation.

[18]  M. Steffes,et al.  Glomerular filtration surface in type I diabetes mellitus. , 1986, Kidney international.

[19]  J. Witztum,et al.  Glucosylation of Low-Density Lipoproteins to an Extent Comparable to That Seen in Diabetes Slows Their Catabolism , 1984, Diabetes.

[20]  C. Mogensen,et al.  The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy , 1983, Diabetes.

[21]  Z. Varghese,et al.  LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE , 1982, The Lancet.

[22]  C. Mogensen.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy , 1982, British medical journal.

[23]  M. Kashyap,et al.  High density lipoproteinuria in nephrotic syndrome. , 1976, Metabolism: clinical and experimental.

[24]  J. Blomhoff,et al.  Possible association between an abnormal low density lipoprotein and nephropathy in lecithin: cholesterol acyltransferase deficiency. , 1974, Clinica chimica acta; international journal of clinical chemistry.

[25]  P. Iverius.  The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans. , 1972, The Journal of biological chemistry.

[26]  W. Yamanaka,et al.  Dietary induced glomerulosclerosis in the guinea pig. , 1967, Archives of pathology.

[27]  S. Wilens,et al.  THE ROLE OF LIPID DEPOSITION IN RENAL ARTERIOLAR SCLEROSIS , 1950, The American journal of the medical sciences.

[28]  M. Taskinen,et al.  Lipoprotein lipase activity and serum lipoproteins in untreated Type 2 (insulin-independent) diabetes associated with obesity , 2004, Diabetologia.

[29]  S. Klahr,et al.  Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  L. Peric-Golia,et al.  Aortic and renal lesions in hypercholesterolemic adult, male, virgin sprague-dawley rats. , 1983, Atherosclerosis.

[31]  B. Volk,et al.  Renal changes in experimental hypercholesterolemia in normal and in subdiabetic rabbits. I. Short term studies. , 1970, Laboratory investigation; a journal of technical methods and pathology.